Researchers are having a tough time recruiting minorities to participate in clinical trials in the multi-billion-dollar effort to get a coronavirus vaccine on the market. It doesn’t help that one person participating in a COVID-19 trial has been left paralyzed, according to reports.
One trial was halted when the test subject suffered spinal cord damage, according to reports. AstraZeneca, which is running the global trial of the vaccine it produced with Oxford University, said the trial volunteer recovered from a severe inflammation of the spinal cord and is no longer hospitalized.
So, it is not shocking that not everyone is
Click to read the full article @African- American News & Issues